Lawyers for four Oklahoma inmates set to receive lethal injections this winter filed an emergency request for a delay on Friday, claiming that a sedative the state plans to use in the executions does not reliably induce the deep coma needed for a humane death and that its use “constitutes human experimentation.”
If no stay is granted, the scheduled execution on Thursday of one of the inmates, Charles Warner, would be the state’s first since the bungled killing of Clayton Lockett in April last year. Lockett gasped and struggled against his restraints before dying 43 minutes into the procedure.
Warner had been scheduled to die the same night, but after the Lockett episode, the state temporarily halted executions to improve training and administration procedures. Warner was condemned to die for the 1997 rape and murder of an 11-month-old girl.
A state inquiry determined that in Lockett’s case, a doctor failed to properly insert an intravenous needle through the prisoner’s groin, causing the sedative and then the paralytic and heart-stopping agents to diffuse in surrounding tissue.
Officials have developed new procedures they say would prevent such an error from recurring. However, they also decided to double the dose of the sedative, midazolam, in future executions.
Last month, a US District Court judge in Oklahoma ruled against a similar appeal for a delay, saying that courts “should not sit as a board of inquiry as to best practices” and asserting that midazolam had been used without problems in about a dozen executions elsewhere.
The same drug was also involved in prolonged executions last year in Ohio and Arizona, and many medical experts say its effects at high dosages are too unknown and unpredictable to justify its use.
Medical experts testifying on behalf of the four prisoners before a US District Court in Oklahama said no scientific evidence existed that a higher dose would reliably induce a coma, challenging the credentials of the physician who testified in favor of the state’s plan.
In medical procedures, midazolam is often used in low doses to relax patients, but it is normally followed with a powerful anesthetic agent.
Midazolam “is not approved for use — nor is it ever used — as general anesthesia for surgical procedures,” according to the emergency request the inmates filed with the 10th US Circuit Court of Appeals in Denver, Colorado.
Because there has been no research or clinical experience with the high doses being tried in executions, many experts say there is no way to reliably predict the effects.
“It is experimentation,” Harvard University anesthesiology associate professor David Waisel said in an interview.
Oklahoma is one of several states trying new drug combinations as barbiturates traditionally used in lethal injections have become scarce.
Florida has executed several prisoners using midazolam at the higher dose now adopted by Oklahoma and followed, in a similar sequence, by a muscle relaxant that impedes breathing and potassium chloride, a caustic agent that stops the heart, but causes excruciating pain if the inmate is not unconscious.
While the Florida executions appeared to go smoothly, Waisel said any failure of the sedative could have gone undetected.
“Once you paralyze an inmate so they cannot move, you have no way of knowing if they are feeling pain,” he said.
On Thursday, Ohio state officials said they would stop using the sedative and delay executions until they could find a source for traditional anesthetics.
Ohio has had a moratorium on executions since January last year, when a prisoner sedated with midazolam and a subsequent narcotic, gasped and clenched his fists for more than 20 minutes.
The pitch is a classic: A young celebrity with no climbing experience spends a year in hard training and scales Mount Everest, succeeding against some — if not all — odds. French YouTuber Ines Benazzouz, known as Inoxtag, brought the story to life with a two-hour-plus documentary about his year preparing for the ultimate challenge. The film, titled Kaizen, proved a smash hit on its release last weekend. Young fans queued around the block to get into a preview screening in Paris, with Inoxtag’s management on Monday saying the film had smashed the box office record for a special cinema
CRITICISM: ‘One has to choose the lesser of two evils,’ Pope Francis said, as he criticized Trump’s anti-immigrant policies and Harris’ pro-choice position Pope Francis on Friday accused both former US president Donald Trump and US Vice President Kamala Harris of being “against life” as he returned to Rome from a 12-day tour of the Asia-Pacific region. The 87-year-old pontiff’s comments on the US presidential hopefuls came as he defied health concerns to connect with believers from the jungle of Papua New Guinea to the skyscrapers of Singapore. It was Francis’ longest trip in duration and distance since becoming head of the world’s nearly 1.4 billion Roman Catholics more than 11 years ago. Despite the marathon visit, he held a long and spirited
‘DISAPPEARED COMPLETELY’: The melting of thousands of glaciers is a major threat to people in the landlocked region that already suffers from a water shortage Near a wooden hut high up in the Kyrgyz mountains, scientist Gulbara Omorova walked to a pile of gray rocks, reminiscing how the same spot was a glacier just a few years ago. At an altitude of 4,000m, the 35-year-old researcher is surrounded by the giant peaks of the towering Tian Shan range that also stretches into China, Kazakhstan and Uzbekistan. The area is home to thousands of glaciers that are melting at an alarming rate in Central Asia, already hard-hit by climate change. A glaciologist, Omarova is recording that process — worried about the future. She hiked six hours to get to
The number of people in Japan aged 100 or older has hit a record high of more than 95,000, almost 90 percent of whom are women, government data showed yesterday. The figures further highlight the slow-burning demographic crisis gripping the world’s fourth-biggest economy as its population ages and shrinks. As of Sept. 1, Japan had 95,119 centenarians, up 2,980 year-on-year, with 83,958 of them women and 11,161 men, the Japanese Ministry of Health said in a statement. On Sunday, separate government data showed that the number of over-65s has hit a record high of 36.25 million, accounting for 29.3 percent of